| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enanta Pharmaceuticals Inc (ENTA) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ENTA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.0K | $13.16M | - | |
| Other | 371.4K | $5.70M | - | |
| Other | 38.3K | $588.0K | - | |
| Other | 30.6K | $469.7K | - | |
| Other | 21.8K | $334.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2024 | Kieffer Tara Lynn54 | Chief Product Strategy Officer | Sell | 2,283 | $8.06 | $18,400.98 | -7.2% | -10.3% | +82.5% | |
| Dec 6, 2024 | Luu Brendan | Chief Business Officer | Sell | 2,283 | $8.06 | $18,400.98 | -6.0% | -10.3% | +82.5% | |
| Dec 6, 2024 | Rottinghaus Scott T.69 | Chief Medical Officer | Sell | 866 | $8.06 | $6,979.96 | -4.6% | -10.3% | +82.5% | |
| Dec 6, 2024 | Or Yat Sun59 | Chief Scientific Officer | Sell | 2,591 | $8.06 | $20,883.46 | -0.7% | -10.3% | +82.5% | |
| Dec 6, 2024 | Mellett Paul J63 | Chief Fin. &Admin Officer | Sell | 2,591 | $8.06 | $20,883.46 | -2.7% | -10.3% | +82.5% | |
| Dec 6, 2024 | Luly Jay R.71 | President And CEO | Sell | 5,142 | $8.06 | $41,444.52 | -0.6% | -10.3% | +82.5% | |
| Jul 15, 2024 | Rottinghaus Scott T.69 | Chief Medical Officer | Sale+OE | 11,945 | $15.97 | $190,746.77 | -15.1% | -31.6% | -60.2% | |
| Jun 17, 2024 | Kieffer Tara Lynn54 | Chief Product Strategy Officer | Sell | 7,266 | $12.33 | $89,589.78 | -18.3% | -2.2% | -41.6% | |
| Dec 13, 2023 | Vance Terry | Director | Sell | 15,295 | $9.12 | $139,490.40 | -72.5% | +49.9% | -35.2% | |
| Dec 5, 2023 | Luu Brendan | Sr. VP, Business Dev. | Sell | 2,125 | $9.63 | $20,463.75 | -5.5% | +65.3% | -9.9% |